Skip to main content
Erschienen in: Rheumatology International 5/2015

01.05.2015 | Original Article - Observational Research

The clinical burden of generalized osteoarthritis represented by self-reported health-related quality of life and activity limitations: a cross-sectional study

verfasst von: Nienke Cuperus, Thea P. M. Vliet Vlieland, Elien A. M. Mahler, Clarinda C. Kersten, Thomas J. Hoogeboom, Cornelia H. M. van den Ende

Erschienen in: Rheumatology International | Ausgabe 5/2015

Einloggen, um Zugang zu erhalten

Abstract

The involvement of multiple joints is common in osteoarthritis (OA), often referred to as generalized osteoarthritis (GOA). However, since research and practice mainly focus on a specific OA localization, the health status of patients with GOA is largely unknown. Therefore, we aimed to describe the clinical burden of GOA in terms of self-reported health-related quality of life (HRQoL) and activity limitations. In this cross-sectional study, individuals clinically diagnosed with GOA and referred to multidisciplinary treatment, completed questionnaires on socio-demographics, joint involvement, HRQoL (SF-36) and activity limitations (HAQ-DI). SF-36 physical (PCS) and mental component summary scores (MCS) were calculated using norm-based data. The patient’s specific most important activity limitations were linked to the International Classification of Functioning, Disability and Health. A total of 147 patients participated [85 % female; mean (SD) age 60 (8) years]. The majority (93 %) had symptomatic OA in both the upper and lower extremities. Predominant joints with symptomatic OA were the hands (85 %) and knees (82 %). Mean (SD) SF-36 PCS and MCS scores were 37 (7) and 48 (10), respectively, showing a broad impact of GOA on the physical component of health. The mean (SD) HAQ-DI score was 1.27 (0.50) indicating moderate to severe functional limitations. Activities concerning mobility and domestic life were considered most important activity limitations, especially walking. The results show a high clinical burden of GOA in terms of HRQoL and activity limitations. This study points to the need of developing non-pharmacological interventions for patients with GOA that should target on improving the physical component of health and mobility limitations.
Literatur
1.
Zurück zum Zitat Bijlsma JW, Berenbaum F, Lafeber FP (2011) Osteoarthritis: an update with relevance for clinical practice. Lancet 377:2115–2126CrossRefPubMed Bijlsma JW, Berenbaum F, Lafeber FP (2011) Osteoarthritis: an update with relevance for clinical practice. Lancet 377:2115–2126CrossRefPubMed
2.
Zurück zum Zitat Petersson IF, Jacobsson LT (2002) Osteoarthritis of the peripheral joints. Best Pract Res Clin Rheumatol 16:741–760CrossRefPubMed Petersson IF, Jacobsson LT (2002) Osteoarthritis of the peripheral joints. Best Pract Res Clin Rheumatol 16:741–760CrossRefPubMed
3.
5.
Zurück zum Zitat Nelson AE, Smith MW, Golightly YM, Jordan JM (2014) “Generalized osteoarthritis”: a systematic review. Semin Arthritis Rheum 43:713–720CrossRefPubMed Nelson AE, Smith MW, Golightly YM, Jordan JM (2014) “Generalized osteoarthritis”: a systematic review. Semin Arthritis Rheum 43:713–720CrossRefPubMed
7.
Zurück zum Zitat Forestier R, Francon A, Briole V, Genty C, Chevalier X, Richette P (2011) Prevalence of generalized osteoarthritis in a population with knee osteoarthritis. Joint Bone Spine 78:275–278CrossRefPubMed Forestier R, Francon A, Briole V, Genty C, Chevalier X, Richette P (2011) Prevalence of generalized osteoarthritis in a population with knee osteoarthritis. Joint Bone Spine 78:275–278CrossRefPubMed
8.
Zurück zum Zitat Gunther KP, Sturmer T, Sauerland S, Zeissig I, Sun Y, Kessler S, Scharf HP, Brenner H, Puhl W (1998) Prevalence of generalised osteoarthritis in patients with advanced hip and knee osteoarthritis: the Ulm Osteoarthritis Study. Ann Rheum Dis 57:717–723CrossRefPubMedCentralPubMed Gunther KP, Sturmer T, Sauerland S, Zeissig I, Sun Y, Kessler S, Scharf HP, Brenner H, Puhl W (1998) Prevalence of generalised osteoarthritis in patients with advanced hip and knee osteoarthritis: the Ulm Osteoarthritis Study. Ann Rheum Dis 57:717–723CrossRefPubMedCentralPubMed
9.
Zurück zum Zitat Min JL, Meulenbelt I, Riyazi N, Kloppenburg M, Houwing-Duistermaat JJ, Seymour AB, Pols HA, van Duijn CM, Slagboom PE (2005) Association of the frizzled-related protein gene with symptomatic osteoarthritis at multiple sites. Arthritis Rheum 52:1077–1080CrossRefPubMed Min JL, Meulenbelt I, Riyazi N, Kloppenburg M, Houwing-Duistermaat JJ, Seymour AB, Pols HA, van Duijn CM, Slagboom PE (2005) Association of the frizzled-related protein gene with symptomatic osteoarthritis at multiple sites. Arthritis Rheum 52:1077–1080CrossRefPubMed
10.
Zurück zum Zitat Hoogeboom TJ, den Broeder AA, Swierstra BA, de Bie RA, van den Ende CH (2012) Joint-pain comorbidity, health status, and medication use in hip and knee osteoarthritis: a cross-sectional study. Arthritis Care Res (Hoboken.) 64:54–58CrossRef Hoogeboom TJ, den Broeder AA, Swierstra BA, de Bie RA, van den Ende CH (2012) Joint-pain comorbidity, health status, and medication use in hip and knee osteoarthritis: a cross-sectional study. Arthritis Care Res (Hoboken.) 64:54–58CrossRef
11.
Zurück zum Zitat Hoogeboom TJ, den Broeder AA, de Bie RA, van den Ende CH (2013) Longitudinal impact of joint pain comorbidity on quality of life and activity levels in knee osteoarthritis: data from the Osteoarthritis Initiative. Rheumatology (Oxford) 52:543–546CrossRef Hoogeboom TJ, den Broeder AA, de Bie RA, van den Ende CH (2013) Longitudinal impact of joint pain comorbidity on quality of life and activity levels in knee osteoarthritis: data from the Osteoarthritis Initiative. Rheumatology (Oxford) 52:543–546CrossRef
12.
Zurück zum Zitat Perruccio AV, Power JD, Evans HM, Mahomed SR, Gandhi R, Mahomed NN, Davis AM (2012) Multiple joint involvement in total knee replacement for osteoarthritis: effects on patient-reported outcomes. Arthritis Care Res (Hoboken.) 64:838–846CrossRef Perruccio AV, Power JD, Evans HM, Mahomed SR, Gandhi R, Mahomed NN, Davis AM (2012) Multiple joint involvement in total knee replacement for osteoarthritis: effects on patient-reported outcomes. Arthritis Care Res (Hoboken.) 64:838–846CrossRef
13.
Zurück zum Zitat Suri P, Morgenroth DC, Kwoh CK, Bean JF, Kalichman L, Hunter DJ (2010) Low back pain and other musculoskeletal pain comorbidities in individuals with symptomatic osteoarthritis of the knee: data from the osteoarthritis initiative. Arthritis Care Res (Hoboken.) 62:1715–1723CrossRef Suri P, Morgenroth DC, Kwoh CK, Bean JF, Kalichman L, Hunter DJ (2010) Low back pain and other musculoskeletal pain comorbidities in individuals with symptomatic osteoarthritis of the knee: data from the osteoarthritis initiative. Arthritis Care Res (Hoboken.) 62:1715–1723CrossRef
14.
Zurück zum Zitat Moe RH, Grotle M, Kjeken I, Hagen KB, Kvien TK, Uhlig T (2013) Disease impact of hand OA compared with hip, knee and generalized disease in specialist rheumatology health care. Rheumatology (Oxford) 52:189–196CrossRef Moe RH, Grotle M, Kjeken I, Hagen KB, Kvien TK, Uhlig T (2013) Disease impact of hand OA compared with hip, knee and generalized disease in specialist rheumatology health care. Rheumatology (Oxford) 52:189–196CrossRef
15.
Zurück zum Zitat Hoogeboom TJ, Stukstette MJ, de Bie RA, Cornelissen J, den Broeder AA, van den Ende CH (2010) Non-pharmacological care for patients with generalized osteoarthritis: design of a randomized clinical trial. BMC Musculoskelet Disord 11:142CrossRefPubMedCentralPubMed Hoogeboom TJ, Stukstette MJ, de Bie RA, Cornelissen J, den Broeder AA, van den Ende CH (2010) Non-pharmacological care for patients with generalized osteoarthritis: design of a randomized clinical trial. BMC Musculoskelet Disord 11:142CrossRefPubMedCentralPubMed
16.
Zurück zum Zitat Vercoulen JH, Swanink CM, Fennis JF, Galama JM, van der Meer JW, Bleijenberg G (1994) Dimensional assessment of chronic fatigue syndrome. J Psychosom Res 38:383–392CrossRefPubMed Vercoulen JH, Swanink CM, Fennis JF, Galama JM, van der Meer JW, Bleijenberg G (1994) Dimensional assessment of chronic fatigue syndrome. J Psychosom Res 38:383–392CrossRefPubMed
17.
Zurück zum Zitat van den Hoven LH, Gorter KJ, Picavet HS (2010) Measuring musculoskeletal pain by questionnaires: the manikin versus written questions. Eur J Pain 14:335–338CrossRefPubMed van den Hoven LH, Gorter KJ, Picavet HS (2010) Measuring musculoskeletal pain by questionnaires: the manikin versus written questions. Eur J Pain 14:335–338CrossRefPubMed
18.
Zurück zum Zitat Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473–483CrossRefPubMed Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473–483CrossRefPubMed
19.
Zurück zum Zitat Aaronson NK, Muller M, Cohen PD, Essink-Bot ML, Fekkes M, Sanderman R, Sprangers MA, te Velde A, Verrips E (1998) Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol 51:1055–1068CrossRefPubMed Aaronson NK, Muller M, Cohen PD, Essink-Bot ML, Fekkes M, Sanderman R, Sprangers MA, te Velde A, Verrips E (1998) Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol 51:1055–1068CrossRefPubMed
20.
Zurück zum Zitat Ware JE Jr, Kosinski M, Bayliss MS, McHorney CA, Rogers WH, Raczek A (1995) Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. Med Care 33:AS264–AS279CrossRefPubMed Ware JE Jr, Kosinski M, Bayliss MS, McHorney CA, Rogers WH, Raczek A (1995) Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. Med Care 33:AS264–AS279CrossRefPubMed
21.
22.
23.
Zurück zum Zitat Beurskens AJ, de Vet HC, Koke AJ, Lindeman E, van der Heijden GJ, Regtop W, Knipschild PG (1999) A patient-specific approach for measuring functional status in low back pain. J Manipulative Physiol Ther 22:144–148CrossRefPubMed Beurskens AJ, de Vet HC, Koke AJ, Lindeman E, van der Heijden GJ, Regtop W, Knipschild PG (1999) A patient-specific approach for measuring functional status in low back pain. J Manipulative Physiol Ther 22:144–148CrossRefPubMed
24.
Zurück zum Zitat Rosengren J, Brodin N (2012) Validity and reliability of the Swedish version of the Patient Specific Functional Scale in patients treated surgically for carpometacarpal joint osteoarthritis. J Hand Ther 26:53–61CrossRefPubMed Rosengren J, Brodin N (2012) Validity and reliability of the Swedish version of the Patient Specific Functional Scale in patients treated surgically for carpometacarpal joint osteoarthritis. J Hand Ther 26:53–61CrossRefPubMed
26.
Zurück zum Zitat Cieza A, Brockow T, Ewert T, Amman E, Kollerits B, Chatterji S, Ustun TB, Stucki G (2002) Linking health-status measurements to the international classification of functioning, disability and health. J Rehabil Med 34:205–210CrossRefPubMed Cieza A, Brockow T, Ewert T, Amman E, Kollerits B, Chatterji S, Ustun TB, Stucki G (2002) Linking health-status measurements to the international classification of functioning, disability and health. J Rehabil Med 34:205–210CrossRefPubMed
27.
Zurück zum Zitat Rupp I, Boshuizen HC, Roorda LD, Dinant HJ, Jacobi CE, van den Bos G (2006) Course of patient-reported health outcomes in rheumatoid arthritis: comparison of longitudinal and cross-sectional approaches. J Rheumatol 33:228–233PubMed Rupp I, Boshuizen HC, Roorda LD, Dinant HJ, Jacobi CE, van den Bos G (2006) Course of patient-reported health outcomes in rheumatoid arthritis: comparison of longitudinal and cross-sectional approaches. J Rheumatol 33:228–233PubMed
28.
Zurück zum Zitat Wolfe F, Michaud K, Li T, Katz RS (2010) EQ-5D and SF-36 quality of life measures in systemic lupus erythematosus: comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, and fibromyalgia. J Rheumatol 37:296–304CrossRefPubMed Wolfe F, Michaud K, Li T, Katz RS (2010) EQ-5D and SF-36 quality of life measures in systemic lupus erythematosus: comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, and fibromyalgia. J Rheumatol 37:296–304CrossRefPubMed
29.
Zurück zum Zitat Bijsterbosch J, Scharloo M, Visser AW, Watt I, Meulenbelt I, Huizinga TW, Kaptein AA, Kloppenburg M (2009) Illness perceptions in patients with osteoarthritis: change over time and association with disability. Arthritis Rheum 61:1054–1061CrossRefPubMed Bijsterbosch J, Scharloo M, Visser AW, Watt I, Meulenbelt I, Huizinga TW, Kaptein AA, Kloppenburg M (2009) Illness perceptions in patients with osteoarthritis: change over time and association with disability. Arthritis Rheum 61:1054–1061CrossRefPubMed
30.
Zurück zum Zitat van Groen MM, ten Klooster PM, Taal E, van de Laar MA, Glas CA (2010) Application of the health assessment questionnaire disability index to various rheumatic diseases. Qual Life Res 19:1255–1263CrossRefPubMedCentralPubMed van Groen MM, ten Klooster PM, Taal E, van de Laar MA, Glas CA (2010) Application of the health assessment questionnaire disability index to various rheumatic diseases. Qual Life Res 19:1255–1263CrossRefPubMedCentralPubMed
31.
Zurück zum Zitat Dreinhofer K, Stucki G, Ewert T, Huber E, Ebenbichler G, Gutenbrunner C, Kostanjsek N, Cieza A (2004) ICF Core Sets for osteoarthritis. J Rehabil Med 44:75–80PubMed Dreinhofer K, Stucki G, Ewert T, Huber E, Ebenbichler G, Gutenbrunner C, Kostanjsek N, Cieza A (2004) ICF Core Sets for osteoarthritis. J Rehabil Med 44:75–80PubMed
32.
Zurück zum Zitat Oberhauser C, Escorpizo R, Boonen A, Stucki G, Cieza A (2013) Statistical validation of the brief International Classification of Functioning, Disability and Health Core Set for osteoarthritis based on a large international sample of patients with osteoarthritis. Arthritis Care Res (Hoboken.) 65:177–186CrossRef Oberhauser C, Escorpizo R, Boonen A, Stucki G, Cieza A (2013) Statistical validation of the brief International Classification of Functioning, Disability and Health Core Set for osteoarthritis based on a large international sample of patients with osteoarthritis. Arthritis Care Res (Hoboken.) 65:177–186CrossRef
33.
Zurück zum Zitat Nelson AE, Elstad E, DeVellis RF, Schwartz TA, Golightly YM, Renner JB, Conaghan PG, Kraus VB, Jordan JM (2013) Composite measures of multi-joint symptoms, but not of radiographic osteoarthritis, are associated with functional outcomes: the Johnston County Osteoarthritis Project. Disabil Rehabil 36:300–306CrossRefPubMedCentralPubMed Nelson AE, Elstad E, DeVellis RF, Schwartz TA, Golightly YM, Renner JB, Conaghan PG, Kraus VB, Jordan JM (2013) Composite measures of multi-joint symptoms, but not of radiographic osteoarthritis, are associated with functional outcomes: the Johnston County Osteoarthritis Project. Disabil Rehabil 36:300–306CrossRefPubMedCentralPubMed
Metadaten
Titel
The clinical burden of generalized osteoarthritis represented by self-reported health-related quality of life and activity limitations: a cross-sectional study
verfasst von
Nienke Cuperus
Thea P. M. Vliet Vlieland
Elien A. M. Mahler
Clarinda C. Kersten
Thomas J. Hoogeboom
Cornelia H. M. van den Ende
Publikationsdatum
01.05.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Rheumatology International / Ausgabe 5/2015
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-014-3149-1

Weitere Artikel der Ausgabe 5/2015

Rheumatology International 5/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.